|
Volumn 143, Issue 5, 2005, Pages 391-392
|
Pegylated interferon-α2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B [2] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTIVIRUS AGENT;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PEGINTERFERON ALPHA2B;
ALPHA2B INTERFERON;
PEGINTERFERON ALFA-2B;
ASSAY;
CHRONIC HEPATITIS;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNE RESPONSE;
LETTER;
PRIORITY JOURNAL;
SEROCONVERSION;
TREATMENT OUTCOME;
VIRUS HEPATITIS;
BLOOD;
NOTE;
ANTIVIRAL AGENTS;
HEPATITIS B E ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
INTERFERON ALFA-2B;
LAMIVUDINE;
|
EID: 24644518899
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-143-5-200509060-00018 Document Type: Letter |
Times cited : (1)
|
References (0)
|